So the stay-at-home father of four in Middleton was crestfallen when his health insurer, Blue Cross Blue Shield of Massachusetts, like others here and elsewhere, stopped covering pricey GLP-1 drugs for weight loss starting Jan. 1. The change meant Tierno’ s $25 monthly prescription would now cost roughly $500 out of pocket, he said, which was out of reach.
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Trump administration unveils $20B reinsurance program to help maritime traffic in Middle East
State Farm won't pursue additional rate hike
Advisor News
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
More Advisor NewsAnnuity News
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
- Retirement is increasingly defined by a secure income stream
- Beyond the S&P 500: The case for RILA diversification
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
More Annuity NewsHealth/Employee Benefits News
- SHOP SMART FOR HEALTH INSURANCE
- CMS announces moratorium on new Medicare hospice/home health enrollment
- EXPANDING MEDICAID COVERAGE LOWERED DEATH RATES FOR YOUNG ADULTS WITH KIDNEY FAILURE
- Insurance won’t cover Ozempic? WA court sparks discrimination debate
- Illinois Quick Hits: Gas tops $5 a gallon
More Health/Employee Benefits NewsLife Insurance News
- New Empathy and LIMRA Research: The Overlooked Opportunity to Engage the Next Generation After an Insurance Payout
- Symetra Names Jeff Sealey Vice President, Stop Loss Captives
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
More Life Insurance News